Assignee profile:

DCB-USA LLC

City:

Wilmington, Delaware

Country:

United States

Published Applications:

24

Last publication date:

2020-05-28

Patent Grants:

22

Last grant date:

2021-12-21

Top Inventors for applications by DCB-USA LLC

These are the the leading inventors for applications assigned to DCB-USA LLC:

Recent patent applications by DCB-USA LLC

DCB-USA LLC based in Wilmington, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-05-28 ✅ Patent 11,202,854 granted on 2021-12-21
US20200164114A1
Human necessities

Disintegrin variants and uses thereof

#2 | 2020-03-19 ✅ Patent 11,142,567 granted on 2021-10-12
US20200087383A1
Chemistry; metallurgy

Anti-dengue virus antibody, pharmaceutical composition comprising the same, and uses thereof

#3 | 2019-09-19 ✅ Patent 11,427,544 granted on 2022-08-30
US20190284141A1
Chemistry; metallurgy

Histone deacetylase 6 inhibitors and use thereof

#4 | 2019-02-28 ✅ Patent 10,980,853 granted on 2021-04-20
US20190060382A1
Human necessities

Process for preparing a crassocephalum crepidioides extract, extract prepared thereby and use of the extract

#5 | 2018-07-26 ✅ Patent 10,745,360 granted on 2020-08-18
US20180208561A1
Chemistry; metallurgy

Quinoxaline compounds, method for preparing the same and use thereof

#6 | 2017-12-28
US20170369525A1
Chemistry; metallurgy

SITE-SPECIFIC CONJUGATION THROUGH GLYCOPROTEINS LINKAGE AND METHOD THEREOF

#7 | 2016-06-30 ✅ Patent 9,527,922 granted on 2016-12-27
US20160185876A1
Chemistry; metallurgy

Humanized alpha-enolase specific antibodies and methods of uses in cancer therapy

#8 | 2016-06-30 ✅ Patent 10,633,453 granted on 2020-04-28
US20160185875A1
Chemistry; metallurgy

Antibody locker for the inactivation of protein drug

#9 | 2016-05-19 ✅ Patent 9,801,888 granted on 2017-10-31
US20160136176A1
Human necessities

Pyrimidine compounds as mTOR and PI3K inhibitors

#10 | 2015-08-06 ✅ Patent 9,969,791 granted on 2018-05-15
US20150218251A1
Chemistry; metallurgy

Modified fibronectin fragments or variants and uses thereof

#11 | 2015-07-09 ✅ Patent 9,090,617 granted on 2015-07-28
US20150191467A1
Chemistry; metallurgy

Agonists of Src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same

#12 | 2014-07-17 ✅ Patent 9,216,950 granted on 2015-12-22
US20140200239A1
Chemistry; metallurgy

Agonists of Src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same

#13 | 2014-07-03 ✅ Patent 9,428,575 granted on 2016-08-30
US20140186352A1
Chemistry; metallurgy

Anti-granulysin antibodies and methods of use thereof

#14 | 2014-06-26 ✅ Patent 9,315,491 granted on 2016-04-19
US20140178360A1
Chemistry; metallurgy

Pyrimidine compounds as mTOR and PI3K inhibitors

#15 | 2013-06-27 ✅ Patent 8,961,971 granted on 2015-02-24
US20130165629A1
Chemistry; metallurgy

Bispecific T-cell activator antibody

#16 | 2012-11-15
US20120288492A1
Chemistry; metallurgy

NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS

#17 | 2012-11-08 ✅ Patent 8,431,118 granted on 2013-04-30
US20120282260A1
Chemistry; metallurgy

Anti-herpes simplex virus antibodies and methods of use thereof

#18 | 2011-09-29 ✅ Patent 8,241,608 granted on 2012-08-14
US20110236424A1
Human necessities

Treating allergy with detoxified heat-labile enterotoxin

#19 | 2011-07-07 ✅ Patent 8,895,497 granted on 2014-11-25
US20110166141A1
Chemistry; metallurgy

Cathepsin S inhibitors

#20 | 2011-02-17 ✅ Patent 8,119,683 granted on 2012-02-21
US20110039880A1
Chemistry; metallurgy

Aryl substituted sulfonamide compounds and their use as anticancer agents

#21 | 2010-07-29 ✅ Patent 8,633,252 granted on 2014-01-21
US20100190732A1
Human necessities

Use of pterosin compounds for treating diabetes and obesity

#22 | 2010-07-08 ✅ Patent 8,252,906 granted on 2012-08-28
US20100172906A1
Chemistry; metallurgy

Anti-herpes simplex virus antibodies and methods of use thereof

#23 | 2010-06-24 ✅ Patent 8,263,570 granted on 2012-09-11
US20100160414A1
Human necessities

Treating picornavirus infection by targeting MicroRNA miR-141

#24 | 2009-06-25 ✅ Patent 7,763,261 granted on 2010-07-27
US20090162378A1
Chemistry; metallurgy

Anti-human cytomegalovirus antibodies

Also check out DCB-USA LLC's (Wilmington, United States) applicant profile with 10 patent applications submitted.

AssigneeID:

28207 ⎘